Cas:79037-25-5 cortisol-1,2-d2 manufacturer & supplier

Chemical Name:cortisol-1,2-d2

CAS.NO:79037-25-5

Synonyms:cortisol-1,2-d2

Molecular Formula:C₂₁H₂₈D₂O₅

Molecular Weight:364.47200

HS Code:

Physical and Chemical Properties:

Melting point:211-214ºC(lit.)

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:94.83000

Exact Mass:364.22200

LogP:1.78160

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like cortisol-1,2-d2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,cortisol-1,2-d2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cortisol-1,2-d2 Use and application,cortisol-1,2-d2 technical grade,usp/ep/jp grade.

Related News: Wuhan officials estimate about 5 million people had left the city for the annual Lunar New Year holiday before authorities canceled all outbound flights, trains and buses in an unprecedented lockdown on January 23. cortisol-1,2-d2 manufacturer It is delivered to hospitals and pharmacies until it reaches the patient. cortisol-1,2-d2 supplier Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. cortisol-1,2-d2 vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn. cortisol-1,2-d2 factory Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms.